Skip to content

Clinical trials

Recruiting Phase 2 Triple Negative Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Phase: Phase 2 Status: Recruiting Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20194
20205
20216
202210
20237
202429
202520
202619

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting102

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University11
Memorial Sloan Kettering Cancer Center4
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University3
Sun Yat-sen University3
UNC Lineberger Comprehensive Cancer Center3
Dana-Farber Cancer Institute2
Emory University2
First Affiliated Hospital of Zhejiang University2
H. Lee Moffitt Cancer Center and Research Institute2
Hebei Medical University Fourth Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms102
Breast Neoplasms43
Neoplasm, Residual3
Brain Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Lung Neoplasms2
Bulbo-Spinal Atrophy, X-Linked1
Colorectal Neoplasms1
Dendritic Cell Sarcoma, Interdigitating1
Hemangiosarcoma1

Trials

Showing 1 to 25 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.